Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and tolerability of repeated doses of
HM11260C when given different regimens in subjects with type 2 diabetes mellitus (T2DM) on
stable metformin monotherapy.